๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wuhan
Clinical trial register · China

Clinical Trials in Wuhan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology165 Tongji Hospital139 Huazhong University of Science and Technology45 Novartis Pharmaceuticals33 AbbVie31
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Wuhan

1343 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Study on the Correlation Between Metabolomics and Anxiety and Depression in Bronchiectasis
NCT07291167Bronchiectasis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
300
Wuhan
2025-12-20
Recruiting
DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes
NCT07263347Breast Neoplasms, Ischemia-Reperfusion Injury, Postoperative Complications, Wound Healing
Hubei Cancer Hospital
Observational
30
Wuhan
2025-12-20
Recruiting
GenSci143 in Participants With Advanced Solid Tumors
NCT07252414Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
180
Zhengzhou, Wuhan, Changsha, Nanjing, Jinan, Shanghai, Taiyuan, Hangzhou
2025-12-20
Not yet open
Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease
NCT07309744Moderate-to-severe Ulcerative Colitis, Crohn's Disease (CD)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
30
Wuhan
2025-12-20
Recruiting
Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT07478731CRC (Colorectal Cancer)
Hong Qiu
Phase 2
48
Wuhan
2025-12-20
Recruiting
Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer
NCT07325565Liver Cancer, Emotional Disorder
Tongji Hospital
Observational
651
Wuhan
2025-12-20
Recruiting
A Phase II Trial of LM103 in Advanced Melanoma
NCT07310784Advanced Melanoma
DrugLM103 TILs
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase 2
92
Beijing, Fuzhou, Guangzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Changchun
2025-12-16
Recruiting
Wearable Device-Based Early Warning of Postoperative Complications in Thoracic Surgery
NCT07646730Postoperative Complications, Thoracic Surgery, Perioperative Monitoring
Tongji Hospital
Observational
650
Wuhan
2025-12-16
Recruiting
A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
NCT07302256Influenza
DrugInfluenza virus split vaccine
Shanghai Institute Of Biological Products
Phase 1
120
Wuhan
2025-12-16
Recruiting
Effectiveness of an Edge AI-based Augmented Reality System for Hand Hygiene Training: a Multi-centre, Mixed-methods Cluster Randomised Controlled Trial
NCT07280026Hand Hygiene Training, Infection Prevention and Control, Healthcare-Associated Infections (HAIs), Health Education
The Hong Kong Polytechnic University
Not applicable
1,000
Wuhan
2025-12-15
Active, closed
A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)
NCT07293065Herpes Zoster
DrugRecombinant Zoster Vaccine
MAXVAX Biotechnology Limited Liability Company
Phase 3
12,000
Shijiazhuang, Zhengzhou, Wuhan, Kunming
2025-12-15
Recruiting
A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
NCT07444307Systemic Lupus Erythematosus (SLE)
Hangzhou Qihan Biotech Co., Ltd.
Phase 1
18
Hefei, Wuhan, Beijing
2025-12-15
Recruiting
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
NCT07307235Type 2 Diabetes
DrugIGlarLixi
Shanghai Zhongshan Hospital
Phase 4
1,316
Hefei, Huizhou, Shenzhen, Harbin, Xinxiang, Wuhan, Changsha, Hengyang
2025-12-13
Recruiting
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
NCT07337785Relapsing or Refractory Multiple Sclerosis (MS), Myasthenia Gravis (MG), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Autoimmune Encephalitis (AE)
Tongji Hospital
Phase EARLY_PHASE1
36
Wuhan
2025-12-12
Recruiting
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
NCT07222800Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms, Neoplasms by Site
DrugsPF-08634404·Bevacizumab
Pfizer
Phase 3
800
Hefei, Beijing, Chongqing, Guangzhou, Meizhou, Nanning, Wuhan, Changsha
2025-12-11
Recruiting
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
NCT07226349Advanced Solid Tumor
DrugsBGB-43395·Fulvestrant
BeOne Medicines
Phase 1
105
Beijing, Guangzhou, Harbin, Wuhan, Nanjing, Jinan, Weifang
2025-12-11
Not yet open
Short-term Observation on the Clinical Application Effect of Astra Tech Implant EV Short Implants for Maxillary Sinus Elevation
NCT07271134Missing Teeth
Linhu Wang
Not applicable
36
Wuhan
2025-12-10
Not yet open
A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia
NCT07297875Achondroplasia
DrugABSK061
Abbisko Therapeutics Co, Ltd
Phase 1/2
110
Beijing, Zhengzhou, Wuhan, Shanghai, Chengde, Chengdu, Hangzhou
2025-12-10
Recruiting
A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders
NCT06904027Urea Cycle Disorders
Tongji Hospital
Observational
40
Beijing, Guangzhou, Wuhan, Shanghai, Hangzhou
2025-12-09
Active, closed
A Multicenter, Randomized, Double-blind, Positive-control, Non-inferiority Clinical Trial on the Effectiveness and Safety of HCA-N Solution for the Preservation of Kidney Grafts During Kidney Transplantation
NCT07825025Kidney Transplant
Zhongnan Hospital
Phase 2/3
250
Wuhan
2025-12-05
Recruiting
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
NCT07209111Neoplasm Malignant
DrugsCalderasib·Pemetrexed
Merck Sharp & Dohme LLC
Phase 2
150
Beijing, Xiamen, Guangzhou, Harbin, Wuhan, Changsha, Nanjing, Nanchang
2025-12-04
Recruiting
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
NCT07283835Non Muscle Invasive Bladder Cancer, High-grade Ta/ T1 Papillary Disease Bladder Cancer
DrugCretostimogene Grenadenorepvec
Lepu Biopharma Co., Ltd.
Phase 2
16
Beijing, Chongqing, Fuzhou, Wuhan, Changsha, Nanjing, Shenyang, Jinan
2025-12-04
Recruiting
A Mixed Cohort, Multicentre Exploratory Study of Non-invasive Quantitative Assessment of Renal Graft Function With Non-contrast Functional Magnetic Resonance Imaging
NCT07333495Kidney Transplant, Renal Allograft Recipients, Renal Allograft
Tongji Hospital
Observational
1,000
Shiyan, Wuhan, Taiyuan
2025-12-04
Recruiting
Influenza Vaccination After Acute Coronary Syndrome
NCT07259252Acute Coronary Syndromes (ACS)
Tongji Hospital
Not applicable
6,620
Wuhan
2025-12-03
Not yet open
Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP
NCT07189910Primary Immune Thrombocytopenia (ITP)
DrugEltrombopag
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4
150
Wuhan
2025-12-01
Recruiting
Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease
NCT07363538Complex Congenital Heart Disease
Central China Fuwai Hospital of Zhengzhou University
Not applicable
738
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Qingdao
2025-12-01
Recruiting
A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofractionated Radiotherapy for Refractory pMMR/MSS Colorectal Cancer
NCT07644286Colorectal Cancer (CRC)
DrugPirfenidone
Tao Zhang
Phase 2
48
Wuhan
2025-12-01
Recruiting
Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer๏ผˆNSCLC๏ผ‰
NCT07388771NSCLC, Neoadjuvant Therapy
Qian Chu
Observational
500
Wuhan, Hangzhou
2025-12-01
Active, closed
Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type Headache
NCT07359248Tension Type Headache
Tongji Hospital
Not applicable
432
Wuhan
2025-12-01
Not yet open
A Multicenter Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by Artificial Intelligence-Based Three-Dimensional Echocardiography
NCT07292896Healthy Adults, Pulmonary Hypertension, Tricuspid Regurgitation, Heart Failure
First Hospital of China Medical University
Observational
2,640
Chongqing, Shenzhen, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Xiangyang, Changchun
2025-12
Recruiting
SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
NCT07474103Rectal Cancer, Adenocarcinoma
DrugsLiposomal Irinotecan·Sintilimab·Oxaliplatin·Capecitabine
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
49
Wuhan
2025-11-30
Recruiting
The Safety and Efficacy of NouvSoma001 in Ischemic Stroke
NCT06612710Ischemic Stroke
Wei Wang
Phase 1
69
Wuhan
2025-11-30
Recruiting
Spectral Precise Image Study for Brain Tumors
NCT07620470Brain Tumors
Philips Clinical & Medical Affairs Global
Observational
120
Wuhan
2025-11-28
Recruiting
FL-261 Imaging for Cancer Diagnosis and Staging
NCT07510321Non-Small Cell Lung Cancer, Colorectal Cancer, Head & Neck Cancer, Advanced Solid Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
12
Wuhan
2025-11-27
Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
NCT07155174Small Cell Lung Cancer
DrugsABBV-706·Lurbinectedin·Atezolizumab·Etoposide
AbbVie
Phase 2
180
Beijing, Zhengzhou, Wuhan, Nanchang, Shanghai, Chengdu
2025-11-25
Not yet open
Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome
NCT07240376Non-Allergic Rhinitis With Eosinophilia Syndrome
DrugStapokibart
Huazhong University of Science and Technology
Not applicable
90
Guangzhou, Wuhan, Xiangyang, Nanchang, Chengdu, Beijing, Shanghai
2025-11-25
Not yet open
Subthalamic Nucleus Versus Globus Pallidal Internus Deep Brain Stimulation for Parkinson Disease
NCT07250685PD - Parkinson's Disease
Zhang Jianguo
Not applicable
86
Beijing, Wuhan, Nanjing, Dalian, Jinan, Shanghai, Tianjin, Hangzhou
2025-11-24
Recruiting
Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of Hypophosphatemia.
NCT07233889Hypophosphatemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
60
Wuhan
2025-11-21
Recruiting
A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])
NCT07208058Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis
DrugPlonmarlimab
TJ Biopharma Co., Ltd.
Phase 3
30
Beijing, Guangzhou, Nanning, Shijiazhuang, Zhengzhou, Wuhan, Nanchang, Shenyang
2025-11-21
Recruiting
IASO208 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies
NCT07309900Relapsed/Refractory B-cell Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
12
Wuhan
2025-11-21
Recruiting
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
NCT07241793Urothelial Carcinoma, Advanced Urothelial Carcinoma, Urothelial Carcinoma Recurrent
DrugsTrastuzumab Rezetecan·Adebrelimab
Sun Yat-sen University
Phase 2
96
Guangzhou, Wuhan, Nanchang, Kunming
2025-11-20
Active, closed
A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome
NCT07211685Alport Syndrome
Bayer
Phase 2
60
Beijing, Chongqing, Guangzhou, Wuhan, Hangzhou
2025-11-19
Recruiting
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
NCT07328841Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen
Phase 3
456
Guangzhou, Shantou, Zhongshan, Nanning, Wuzhou, Wuhan, Changsha, Guangdong
2025-11-18
Not yet open
A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia
NCT07233018Relapsed/Refractory Acute Myeloid Leukemia(AML)
MEI HENG
Phase 1
24
Wuhan
2025-11-18
Recruiting
Somatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior Resection
NCT07605611Rectal Cancer, Anastomotic Leakage
DrugSomatostatin
Tongji Hospital
Not applicable
72
Ezhou, Wuhan
2025-11-17
Recruiting
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
NCT07002346Ovarian Clear Cell Carcinoma
DrugsIparomlimab and Tuvonralimab·Carboplatin·Paclitaxel·Bevacizumab
Tongji Hospital
Phase 3
226
Wuhan
2025-11-15
Recruiting
TIPS With or Without BCAA
NCT07281846BCAA, Cirrhosis, Portal Hypertension Related to Cirrhosis, Sarcopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
164
Wuhan
2025-11-15
Recruiting
Artificial Intelligence-Assisted vs Surgeon-Planned Trajectories in Freehand Femoral Neck Screw Fixation
NCT06937138Femoral Neck Fractures
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
334
Wuhan
2025-11-14
Recruiting
Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit Constipation
NCT07277907Slow Transit Constipation, Pharmacotherapy
DrugsLubiprostone·Polyethylene glycol
Third Military Medical University
Phase 3
346
Bishan, Hechuan, Shapingba, Yuzhong, Lanzhou, Shijiazhuang, Harbin, Wuhan
2025-11-13
Recruiting
Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
NCT07206758Immune Thrombocytopenia
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 1
10
Wuhan
2025-11-12
Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
NCT07225504Secondary Progressive Multiple Sclerosis (SPMS)
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 3
1,275
Guangzhou, Zhengzhou, Wuhan, Hohhot, Suzhou, Changchun, Shenyang, Yinchuan
2025-11-11
Recruiting
A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics
NCT07260500Short Stature Children Born Small for Gestational Age (SGA)
DrugPEG-rhGH
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
72
Wuhan
2025-11-11
Recruiting
Real-world Study of Aflibercept 8 mg in nAMD
NCT07640997Neovascular Age-Related Macular Degeneration (nAMD)
DrugAflibercept
Peking University People's Hospital
Observational
300
Beijing, Fuzhou, Shenzhen, Zunyi, Harbin, Nanyang, Wuhan, Hohhot
2025-11-11
Recruiting
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
NCT07228364Autosomal Dominant Polycystic Kidney Disease
DrugAZD1613
AstraZeneca
Phase 1
40
Chengdu, Hangzhou, Nanjing, Shanghai, Wuhan, Xiamen
2025-11-10
Recruiting
A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors
NCT07265921Advanced Solid Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
232
Beijing, Nanjing, Shanghai, Tianjin, Wuhan
2025-11-07
Recruiting
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
NCT07100080Non-Small Cell Lung Cancer
DrugsIza-bren·Pemetrexed·Cisplatin·Carboplatin
Bristol-Myers Squibb
Phase 2/3
500
Beijing, Chongqing, Fuzhou, Jiangmen, Anyang, Luoyang, Jingzhou, Wuhan
2025-11-05
Active, closed
the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases
NCT07339540Recurrent or Refractory Systemic Lupus Erythematosus, Recurrent or Refractory IgG4 Related Diseases, Recurrent or Refractory Systemic Sclerosis, Recurrent or Refractory Idiopathic Inflammatory Myopathy
Tongji Hospital
Phase EARLY_PHASE1
45
Wuhan
2025-11-04
Recruiting
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
NCT07108283Nonsegmental Vitiligo
DrugZasocitinib
Takeda
Phase 2
200
Wuhan, Xi'an, Shanghai, Kunming, Hangzhou
2025-11-03
Recruiting
Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC
NCT07291401Rectal Cancer Patients
Zhongnan Hospital
Phase 2
108
Wuhan
2025-11-01
Recruiting
Deep Learning-Based Multidimensional Body Composition Mapping for Outcome Prediction in HCC Patients Undergoing TACE
NCT07235410Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
300
Wuhan
2025-11-01
Not yet open
A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers
NCT07233850Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Oesophageal Cancer
DrugsAG·TP·Xelox·Bevacizumab
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 2
300
Wuhan
2025-11
Recruiting
To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
NCT07208591Acute Respiratory Distress Syndrome (ARDS)
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Phase 3
406
Beijing, Xiamen, Guangzhou, Zunyi, Luoyang, Zhengzhou, Wuhan, Xiangtan
2025-10-31
Recruiting
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
NCT07205822Breast Cancer
DrugDato-DXd
AstraZeneca
Phase 3
100
Beijing, Changsha, Guangzhou, Linyi, Shandong, Wuhan, Zhengzhou
2025-10-30
Recruiting
Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.
NCT07569653Cytomegalovirus Infections, Cytomegalovirus Disease, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease
WeiShi
Phase 4
120
Beijing, Shijiazhuang, Zhengzhou, Jingzhou, Wuhan, Hohhot, Nanchang, Wenzhou
2025-10-30
Recruiting
BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation
NCT07246031Graft -Versus-host-disease, aGVHD, Haploidentical Stem Cell Transplantation, cGVHD
BioPhoenix Co., Ltd.
Phase 2
50
Beijing, Wuhan
2025-10-29
Recruiting
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
NCT07250269Relapsed/Refractory AL Amyloidosis
DrugGC012F
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1
9
Beijing, Changchun, Guangzhou, Hangzhou, Suzhou, Wenzhou, Wuhan
2025-10-29
Recruiting
Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies
NCT07240974Relapsed/Refractory B-cell Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
6
Wuhan
2025-10-28
Recruiting
Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention
NCT07282184Hepotacellular Carcinoma
Tongji Hospital
Phase 1/2
144
Wuhan
2025-10-26
Recruiting
Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases
NCT07469267Breast Cancer, Radiotherapy
Fudan University
Not applicable
1,608
Guiyang, Shijiazhuang, Harbin, Wuhan, Changde, Changsha, Dalian, Jinan
2025-10-24
Recruiting
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
NCT07272434Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company
Phase 3
25,000
Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Changsha, Xi'an, Jinan, Chengdu
2025-10-22
Recruiting
Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window
NCT06987305Stroke, Acute Ischemic
Xinqiao Hospital of Chongqing
Phase 3
820
Wuhan, Xiangtan, Jiujiang, Nanchang
2025-10-21
Recruiting
A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation
NCT07259590Advanced Solid Tumors Cancer, PDAC, CRC (Colorectal Cancer)
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
126
Beijing, Guangzhou, Zhengzhou, Wuhan
2025-10-21
Recruiting
Desflurane vs. Propofol for Cardiac Anesthesia
NCT07116733Cardiac Surgery, Coronary Artery Bypass Grafting
Xijing Hospital
Phase 3
3,560
Fuzhou, Cangzhou, Shijiazhuang, Zhengzhou, Wuhan, Nanjin, Xi'an, Chengdu
2025-10-20
Recruiting
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
NCT07209761Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
532
Beijing, Fuzhou, Shenzhen, Wuhan, Nanjing, Jinan, Shanghai, Chengdu
2025-10-16
Active, closed
A Study Evaluating BAT3306 Compared With Keytrudaยฎ in NSCLC Cancer Participants
NCT07180862Carcinoma, Non-Small-Cell Lung
Bio-Thera Solutions
Phase 1
160
Wuhan
2025-10-14
Recruiting
Burst Stimulation for Paroxysmal Atrial Fibrillation
NCT07281898Paroxysmal Atrial Fibrillation
Zhibing Lu
Not applicable
240
Wuhan, Xiangyang, Yichang
2025-10-13
Recruiting
A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)
NCT07129343Von Willebrand Disease (VWD)
DrugAdvate
Takeda
Phase 3
20
Beijing, Guangzhou, Jihan, Shanghai, Suzhou, Tianjin, Wuhan
2025-10-13
Not yet open
A Study of CAR-T Cells in Subjects With Systemic Lupus Erythematosus
NCT06900764Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
24
Wuhan
2025-10-10
By invitation
BMI Stratified Management Based on Meridian-Lymph Axis Theory for Lower Extremity Lymphedema After Gynecologic Cancer Surgery
NCT07374835Lower Extremity Lymphedema After Gynecologic Cancer Surgery
Hong Zhang
Not applicable
60
Wuhan
2025-10-09
Recruiting
Bupivacaine Liposomes or Bupivacaine for CMB on Postoperative Analgesia in Laparoscopic Hepatobiliary Pancreatic Surgery
NCT06737341Bupivacaine, Ultrasound-Guided, Analgesia, Postoperative, Opioids
DrugsBupivacaine Liposomes·Bupivacaine
Huazhong University of Science and Technology
Phase 4
60
Wuhan
2025-10-08
Not yet open
Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNP
NCT07200336Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
DrugMepolizumab
Eye & ENT Hospital of Fudan University
Phase 4
360
Chongqing, Fuzhou, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Nanjing
2025-10-08
Recruiting
The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis
NCT07539675Primary Angle-Closure Glaucoma
Zhongnan Hospital
Observational
150
Wuhan
2025-10-01
Not yet open
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors
NCT07172503Colorectal Cancer, Gastric Cancer (GC), Pancreatic Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
56
Wuhan
2025-10-01
Not yet open
Penfluridol for Relapsed/Refractory Small Cell Cancers
NCT07206563Small Cell Carcinoma, Small Cell Carcinoma of Lung, Small Cell Lung Cancer ( SCLC ), Small Cell Cervical Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1/2
33
Wuhan
2025-10-01
Recruiting
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
NCT07181161Metastatic Prostate Cancer
DrugPalacaparib
AstraZeneca
Phase 1/2
283
Changsha, Chengdu, Wuhan
2025-10-01
Not yet open
A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.
NCT06364904Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
210
Guangzhou, Wuhan, Changsha
2025-10
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
NCT07144280Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma
DrugsPF-08046054·Paclitaxel
Pfizer
Phase 3
680
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Harbin, Wuhan
2025-09-29
Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT06979336Ulcerative Colitis
Genentech, Inc.
Phase 2
224
Fuzhou, Xiamen, Guangzhou, Huizhou, Zhengzhou, Wuhan, Changchun, Binzhou
2025-09-29
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naรฏve.
NCT07028853Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsMevrometostat·Enzalutamide
Pfizer
Phase 3
1,000
Wuhu, Beijing, Chongqing, Lanzhou, Guangzhou, Wuhan, Changsha, Huai'an
2025-09-28
Recruiting
Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma
NCT07177443Locally Advanced Nasopharyngeal Carcinoma
DrugsSerplulimab·Cisplatin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3
710
Wuhan
2025-09-26
Recruiting
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
NCT07190196Immunoglobulin G4 Related Disease
DrugsGlucocorticoid·Rilzabrutinib
Sanofi
Phase 3
124
Beijing, Chengdu, Hangzhou, Jiazhuang, Taiyuan, Wuhan, Yantai
2025-09-26
Recruiting
PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
NCT07188610CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 2
100
Hefei, Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing, Suzhou
2025-09-25
Not yet open
A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.
NCT07199257Allergic Rhinitis, Seasonal
DrugGR1802
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 3
144
Wuhan
2025-09-25
Recruiting
Effects of Remimazolam and Ciprofol TIVA on PRAE in Pediatric Tonsillectomy and Adenoidectomy
NCT07118579Tonsillectomy With or Without Adenoidectomy
Tongji Hospital
Phase 4
114
Wuhan
2025-09-23
Recruiting
A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)
NCT07154264Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
DrugsDZD8586·Venetoclax
Dizal Pharmaceuticals
Phase 2
66
Hefei, Beijing, Guangzhou, Zhengzhou, Wuhan, Yichang, Changsha, Changzhou
2025-09-22
Recruiting
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib
NCT07164170Non-Small Cell Lung Cancer
DrugsABSK043·Glecirasib
Abbisko Therapeutics Co, Ltd
Phase 2
86
Hefei, Beijing, Fuzhou, Guangzhou, Nanning, Harbin, Zhengzhou, Wuhan
2025-09-22
Recruiting
A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
NCT07170800Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
DrugDelamanid
WestVac Biopharma Co., Ltd.
Phase 2
60
Wuhan, Changsha, Nanjing, Jinan, Chengdu, Beijing, Shanghai
2025-09-19
Recruiting
JS207 Combination Therapy in Triple-negative Breast Cancer
NCT07045311Triple-negative Breast Cancer
Drugs9MW2821·JS207·Albumin paclitaxel
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
80
Hefei, Beijing, Guangzhou, Baoding, Harbin, Zhangzhou, Wuhan, Nanjing
2025-09-17
Recruiting
LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma
NCT07100067Relapsed/Refractory Multiple Myeloma(MM)
Nanjing Legend Biotech Co.
Not applicable
35
Beijing, Tianjin, Wuhan
2025-09-16
Active, closed
Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers
NCT06990256Sleep Disorder, Aging
Huazhong University of Science and Technology
Not applicable
83
Wuhan
2025-09-16
Rows per page Showing 301–400 of 1343
Previous 2 3 4 5 6 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/wuhan?page=4

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,343 of those studies with a site in Wuhan.

How many clinical trials are recruiting in Wuhan?

798 of the 1,343 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 226 have not yet opened recruitment, 281 are active but closed to new participants, and 38 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.